Decarbonising respiratory care and improving patient outcomes

References

1.  WHO. Climate change and health. [Online]. Available at: [Accessed August 2023]

2.  WHO. Ambient (outdoor) air pollution. [Online]. Available at: [Accessed August 2023]

3.  Wilkinson A. et al. Greenhouse gas emissions associated with asthma care in the UK: results from SABINA CARBON. Oral session presented at the 10th International Primary Care Respiratory Group (IPCRG) World Conference, 2021 May 6-8; Dublin, Ireland.

4.  ARUP. Health care’s climate footprint. [Online]. Available at: [Accessed August 2023]

5.  SMI. Decarbonising patient care pathways. [Online]. Available at: [Accessed August 2023]

6.  Wu Y et al. Front Public Health. Global Burden of Respiratory Diseases Attributable to Ambient Particulate Matter Pollution: Findings From the Global Burden of Disease Study 2019. 2021;9: doi: 10.3389/fpubh.2021.

7.  Usmani OS, et al. Real-world impact of non-clinical inhaler regimen switches on asthma or COPD: a systematic review. JACI: In Practice. 2022:10(10);2625-2637.

8.  Doyle S, et al. What happens to patients who have their asthma device switched without their consent? Prim Care Respir J. 2010; 19 (2): 131–139. 

9.  Bjermer L. The Importance of continuity in inhaler device choice for asthma and chronic obstructive pulmonary. Respiration. 2014;88(4):346-52.

10. AstraZeneca. AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next- generation respiratory inhalers. Available at: AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers. [Accessed August 2023]

11. Wallington TJ, Sulbaek Andersen MP, Nielsen OJ. Atmospheric chemistry of short-chain haloolefins: photochemical ozone creation potentials (POCPs), global warming potentials (GWPs), and ozone depletion potentials (ODPs). Chemosphere. 2015;129:135-141.

12. ECHA Dossier – 1-Propene, 1,3,3,3-tetrafluoro-. Available at: dossier/31292/2/3. [Accessed August 2023]

13. A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers. Available at: [Accessed August 2023]